NCT06370923

Brief Summary

Novel strategies are needed to engage men in Sub Saharan Africa (SSA) with HIV testing, treatment and prevention services to drive the epidemic towards elimination. Suboptimal engagement with HIV prevention by men increases their risk of HIV acquisition, and is an important driver of new HIV infections in women. HIV self-testing (HIVST) addresses several key facility-based access barriers and HIVST distribution through leveraging male peer networks for HIV prevention is feasible, acceptable and effective in SSA. The objective of this project is to use an implementation science approach to establish the impact of HIVST distribution through male social networks, with phone-based support and improved risk perception, on PrEP (Pre-Exposure Prophylaxis) uptake among men in Eastern Zimbabwe. The project will leverage infrastructure and data associated with 20-year programme of HIV surveillance and behavioural research in a well-characterized population cohort hosted by the Manicaland Centre for Public Health Research, Zimbabwe. The study will utilise a cluster randomised design of 44 clusters (22 Intervention:22 control) comprising on average 81 men in each cluster (total N = 3591) followed for 6 months (giving \>80% power to detect a difference in PrEP initiation among men of 2% versus 8.5%). In intervention clusters the investigators will identify initial distributors who will receive an HIVST kit for personal use and HIVST kits to distribute to local peers. These peers can subsequently become distributors, allowing the intervention to propagate through peer networks. A toll-free helpline will provide pre- and post-test support and an SMS (Short Message Service) -based risk assessment will expedite PrEP initiation at the clinic. The study team will conduct a performance (process) evaluation of the intervention. to assess implementation fidelity, causal mechanisms underlying trial effectiveness including how characteristics of peer networks affect outcomes. Results of the study will be used to quantify the population level impacts and cost-effectiveness of male peer to peer HIVST distribution strategies on the uptake of PrEP in HIV hyper-endemic settings using a fully calibrated individual-based mathematical model. The envisaged long-term impact of this research is the development of a generalizable, multicomponent male peer-based HIVST and PrEP uptake model for settings where HIV incidence is high.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,591

participants targeted

Target at P75+ for not_applicable hiv-infections

Timeline
25mo left

Started Oct 2024

Typical duration for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Oct 2024May 2028

First Submitted

Initial submission to the registry

March 18, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

October 21, 2024

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2028

Last Updated

May 4, 2025

Status Verified

May 1, 2025

Enrollment Period

3.6 years

First QC Date

March 18, 2024

Last Update Submit

May 2, 2025

Conditions

Keywords

HIV self testHIV Pre Exposure ProphylaxisPeer Networks

Outcome Measures

Primary Outcomes (1)

  • HIV pre-exposure prophylaxis (PrEP) initiation

    A comparison between the intervention and control arms of the proportions of men aged 18 and above initiating PrEP

    Up to 6 months from the start of HIVST distribution in the local intervention clusters

Secondary Outcomes (7)

  • Antiretroviral Therapy initiation

    Up to 6 months from the start of HIVST distribution in the local intervention clusters

  • Antiretroviral Therapy or HIV pre-exposure prophylaxis (PrEP) initiation

    Up to 6 months from the start of HIVST distribution in the local intervention clusters

  • HIV testing

    Up to 6 months from the start of HIVST distribution in the local intervention clusters

  • Confirmed positive HIV test

    Up to 6 months from the start of HIVST distribution in the local intervention clusters

  • HIV testing after the use of an HIV self test

    Up to 6 months from the start of HIVST distribution in the local intervention clusters

  • +2 more secondary outcomes

Study Arms (2)

Peer Distribution

EXPERIMENTAL

In intervention clusters investigators will identify initial distributors who will receive an HIVST kit for personal use and HIVST kits to distribute to local peers. These peers can subsequently become distributors, allowing the intervention to propagate through peer networks. A toll-free helpline will provide pre- and post-test support and an SMS-based risk assessment will expedite PrEP initiation at the clinic.

Behavioral: Peer Distribution

Community Health Worker Distribution

ACTIVE COMPARATOR

This will be the Standard of Care, HIVST kits distributed by Community health workers in the Control clusters.

Behavioral: Community Health Worker Distribution

Interventions

In intervention clusters investigators will identify initial distributors who will receive an HIVST kit for personal use and HIVST kits to distribute to local peers. These peers can subsequently become distributors, allowing the intervention to propagate through peer networks. A toll-free helpline will provide pre- and post-test support and an SMS-based risk assessment will expedite PrEP initiation at the clinic.

Peer Distribution

Distribution of HIV self tests by community health workers

Community Health Worker Distribution

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Resident in study site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BRTI - Manicaland Centre for Public Health Research

Mutare, Manicaland Province, Zimbabwe

RECRUITING

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Frank Tanser, PhD

    University of Stellenbosch

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Constance Nyamukapa, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Analysts blinded to allocation
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Cluster randomised trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 18, 2024

First Posted

April 17, 2024

Study Start

October 21, 2024

Primary Completion (Estimated)

May 31, 2028

Study Completion (Estimated)

May 31, 2028

Last Updated

May 4, 2025

Record last verified: 2025-05

Locations